All In Biotech

Drug Trial Radar · NCT06192472

Investigation Into the Pathophysiology and Treatment of Varicose Veins

Last checked: Nov 20, 2026Latest source record: Jan 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Apr 2013

Primary completion

Jul 2015

Study completion Sep 2015

Sponsor

Lead sponsor
University of SurreyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The Whiteley Clinic
First posted
Jan 5, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Chemical sclerotherapy is commonly used to treat varicose veins which affect superficial veins in the leg. Sclerotherapy is injected directly into veins where it causes damage to the vein wall. If sufficient damage occurs, the vein is transformed into a fibrous cord which does not re-open. This study will investigate the structural changes caused to the wall of veins following injection with sclerotherapy ex vivo. Vein samples will be obtained from the Whiteley Clinic in Guildford from patients undergoing phlebectomy operations. These will then be injected with sclerotherapy and the extent of damage will be investigated. Samples will also be used for laboratory analysis into the pathophysiology of varicose veins.

Conditions

  • Varicose Veins

Interventions

  • Chemical sclerotherapyProcedure

    Sclerosant will be retained within the vein

  • 1% Sodium Tetradecyl SulphateDrug

    1% Sodium Tetradecyl Sulphate

  • 3% Sodium Tetradecyl SulphateDrug

    3% Sodium Tetradecyl Sulphate

  • 0.5% PolidocanolDrug

    0.5% Polidocanol

  • 3% PolidcanolDrug

    3% Polidcanol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To identify the mechanisms responsible for the therapeutic effects of sclerotherapy in varicose veins.Time frame: 2 years 4 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • The Whiteley Clinic

    Guildford, Surrey, United Kingdom

  • University of Surrey

    Guildford, Surrey, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.